Please login to the form below

Not currently logged in


This page shows the latest benznidazole news and features for those working in and with pharma, biotech and healthcare.

Post-Shkreli KaloBios pledges transparent pricing

Post-Shkreli KaloBios pledges transparent pricing

We are not conducting original research on benznidazole and therefore do not plan to incorporate an 'R&D premium' into the price," he asserted. ... In the US benznidazole would be made available regardless of their ability to pay, while the drug will be

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...